[Guideline for diagnosis and treatment of immune thrombocytopenia]

Area of Science:

• Hematology
• Immunology
• Internal Medicine

Background:

• Immune thrombocytopenia (ITP) management, prognosis, and treatment are subjects of ongoing debate among experts.
• Existing guidelines offer differing opinions, highlighting the lack of a universal consensus on ITP care.

Purpose of the Study:

• To establish clear diagnostic criteria for immune thrombocytopenia.
• To outline initial laboratory investigations and differential diagnoses for ITP.
• To provide comprehensive guidance on prognosis, outcomes, and treatment strategies for acute and chronic ITP, including managing severe bleeding.

Main Methods:

• Systematic review of existing literature and expert opinion synthesis.
• Development of consensus-based recommendations for diagnosis and management.
• Classification of treatment options based on disease severity and chronicity.

Main Results:

• Defined specific diagnostic criteria and recommended initial laboratory tests for ITP.
• Established differential diagnostic pathways to distinguish ITP from other conditions.
• Summarized prognostic indicators and outlined therapeutic interventions for various ITP presentations.

Conclusions:

• This guideline aims to standardize the approach to immune thrombocytopenia diagnosis and management.
• It offers a framework for clinicians to optimize patient outcomes and address life-threatening bleeding in ITP.
• Achieving a consensus on ITP management is crucial for improving patient care globally.